Exosome Diagnostics Completes $30 Million Series C Financing

Jul 24, 2017

|

NEW YORK (GenomeWeb) – Exosome Diagnostics said today that it has closed a $30 million Series C financing, led by Tiger Partners and Forbion Capital Partners.

Other participants included Blue Ridge Capital, NGN Capital, Arcus Ventures, b-to-v Partners, and CD Ventures among others.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Exosome Diagnostics Completes $30 Million Series C Financing

To read the full story....

Breaking News

GenScript Biotech, IES Diagnostics Partner to Distribute SARS-CoV-2 Antibody Kit

NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date

RenalytixAI, Joslin Diabetes Center Ink Kidney Disease IP Agreement

Calciscon Raises $2.7M in Series A Round

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

What's Popular?

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

Calciscon Raises $2.7M in Series A Round

Ortho Clinical Diagnostics Gets Additional CE Mark for Coronavirus Antigen Test

Sponsorships